PCI Biotech first quarter 2021 interim results
07 mai 2021 01h00 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 7 May 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim Q1 2021 results. Please find enclosed the report and presentation. ...
PCI Biotech: US patent for the vaccine technology (fimaVacc) with a new important class of adjuvants
26 mars 2020 04h12 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 26 March 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces that the U.S. Patent and Trademark Office (USPTO) has informed the company that a...
PCI Biotech: US patent granted for the vaccine technology (fimaVacc) in combination with cytokines
21 janv. 2020 02h00 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 21 January 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces that the U.S. Patent and Trademark Office (USPTO) has granted the company a US...